Product Information
APLENZIN ER 174 MG TABLET is a brand product labeled by Bausch Health US LLC, priced at $70.8674 per EA under NDC 00187581030. Its NADAC has been published 260 times since May 13, 2015.
Strength
174 mg/1
Manufacturer
Bausch Health US LLCNDC
00187581030
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
9/17/2025
Active Ingredients
BUPROPION HYDROBROMIDEApproval Type
New Drug (NDA)
FDA Application
NDA022108On Market Since
4/23/2008
Pharmacological Classes
Price Statistics
The NADAC for APLENZIN ER 174 MG TABLET has been published 260 times since May 13, 2015, and over the history we have for it it has risen 231.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $70.8674 per EA |
|---|---|
| All-time high | $71.0087 (May 14, 2025) |
| All-time low | $21.3767 (May 13, 2015) |
| 52-week high | $70.9605 |
| 52-week low | $70.8674 |
| Median price | $58.9182 |
| Average price | $58.6101 |
| Largest weekly change | +122.9% (Nov 18, 2020) |
| Weeks tracked | 260 |
| Tracking since | May 13, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the bupropion hydrobromide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of APLENZIN ER 174 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for APLENZIN ER 174 MG TABLET, manufactured by Bausch Health US LLC, is $70.8674 per EA (NDC 00187581030), effective Oct 1, 2025.
How has the price of APLENZIN ER 174 MG TABLET changed over time?
Over the history we have for it, the NADAC for APLENZIN ER 174 MG TABLET has risen 231.5%. It has been tracked across 260 weekly CMS publications since May 13, 2015.
What are the highest and lowest recorded NADAC prices for APLENZIN ER 174 MG TABLET?
Since May 13, 2015, the NADAC for APLENZIN ER 174 MG TABLET has ranged from a low of $21.3767 (May 13, 2015) to a high of $71.0087 (May 14, 2025), with a median of $58.9182 per EA.
Are there cheaper alternatives to APLENZIN ER 174 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of APLENZIN ER 174 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures APLENZIN ER 174 MG TABLET?
APLENZIN ER 174 MG TABLET (NDC 00187581030) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification